- Home
- BOF vs PULM Comparison
BOF vs PULM Comparison
Compare BOF & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- PULM
- Stock Information
- Founded
- BOF 2017
- PULM 2003
- Country
- BOF United States
- PULM United States
- Employees
- BOF N/A
- PULM N/A
- Industry
- BOF Packaged Foods
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- BOF Consumer Staples
- PULM Health Care
- Exchange
- BOF Nasdaq
- PULM Nasdaq
- Market Cap
- BOF 21.2M
- PULM 20.5M
- IPO Year
- BOF 2023
- PULM N/A
- Fundamental
- Price
- BOF $2.22
- PULM $5.33
- Analyst Decision
- BOF
- PULM
- Analyst Count
- BOF 0
- PULM 0
- Target Price
- BOF N/A
- PULM N/A
- AVG Volume (30 Days)
- BOF 514.6K
- PULM 9.0K
- Earning Date
- BOF 08-13-2025
- PULM 08-12-2025
- Dividend Yield
- BOF N/A
- PULM N/A
- EPS Growth
- BOF N/A
- PULM N/A
- EPS
- BOF N/A
- PULM N/A
- Revenue
- BOF $8,242,843.00
- PULM $1,921,000.00
- Revenue This Year
- BOF N/A
- PULM N/A
- Revenue Next Year
- BOF N/A
- PULM $134.88
- P/E Ratio
- BOF N/A
- PULM N/A
- Revenue Growth
- BOF 96.47
- PULM N/A
- 52 Week Low
- BOF $0.61
- PULM $1.78
- 52 Week High
- BOF $4.11
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- BOF 40.65
- PULM 33.68
- Support Level
- BOF $2.35
- PULM $5.20
- Resistance Level
- BOF $2.69
- PULM $5.77
- Average True Range (ATR)
- BOF 0.17
- PULM 0.29
- MACD
- BOF -0.08
- PULM -0.03
- Stochastic Oscillator
- BOF 2.22
- PULM 9.93
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).